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Background: The non-operative treatment of herniated intervertebral discs has long been 
a fundamental challenge. A novel technique of laser ablation to ablate the nucleus pulposus 
under a transforaminal epiduroscope (TELA system, Lutronics, Seoul, Republic of Korea) was 
recently developed.
Objective: The purpose of this study was to evaluate the safety and effectiveness of 
transforaminal epiduroscopic laser ablation (TELA) for selective ablation of the nucleus 
pulposus in single-level disc disease.
Study Design: Prospective case control study
Setting: Multicenter study
Methods: This study included a group of 56 patients who underwent transforaminal 
epiduroscopic laser ablation (TELA) and 56 patients who underwent selective transforaminal 
epidural block (STEB) for single-level disc disease. Visual analog scale (VAS), Oswestry 
Disability Index (ODI), and SF-12 were assessed at admission and at 1, 3, 6, and 12 months 
postoperatively.
Results: The mean VAS of back pain was lower for the TELA group than for the STEB group 
12 months postoperative (P < 0.05). The mean ODI was lower in the TELA group than in the 
STEB group at 12 months postoperatively (P < 0.05). There were no major complications 
related to the TELA and STEB procedures.
Limitations: The primary limitation is a small sample size. The control group was created 
from a database which was prospectively collected in a different time line.
Conclusions: The TELA procedure is superior to the STEB procedure in terms of patients 
reporting less pain and better quality of life over a year. TELA may be a reasonable alternative 
to conventional interventions or open surgery in single-level disc disease.
Key words: Laser-assisted spinal endoscopy, disc decompression, Nd:YAG laser, laser 
ablation, intervertebral disc disease, lumbar spine
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percutaneous elimination of the nucleus pulposus 
and modulation of the annulus fibrosus (1,2). The 
advantage of percutaneous laser disc decompression 
(PLDD) includes avoidance of general anesthesia, a 
shorter hospital stay, a lack of postoperative epidural 
The non-operative treatment of herniated intervertebral discs has long been a fundamental challenge under investigation, 
and has spurred considerable technological 
innovation. Laser ablation has been used for 
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Methods
This was a multicenter, prospective, case control 
study. Approval from the institutional review board was 
obtained in each institute. A total of 56 patients were 
consecutively enrolled in the TELA group from 2015 to 
2016. Selective transforaminal epidural block (STEB) 
was the control. The same number of control patients 
matched by age and gender from a previously-collected 
patient database. The details are presented in Table 1.
Indications
All patients had suffered from chronic lower back 
or leg pain for at least 3 months. Inclusion criteria were 
single level herniated lumbar disc (HLD) at the level 
of L3-4 to L5-S1 in patients between ages 18 and 80. 
All patients had suffered from chronic lower back or 
leg pain for at least 3 months. Single level HLD diag-
nosis was based on MRI findings, clinical symptoms, 
and neurological examinations. For the TELA group, 
conventional epidural steroid injections had failed to 
provide acceptable pain relief. Patients with multi-level 
HLD, lumbar stenosis, lumbar spondylolisthesis, spinal 
instability, cauda equina syndrome, infections, tumor-
ous conditions, litigations, and compensation problems 
were excluded. Informed consent was obtained for all 
patients.
TELA Procedure
TELA was performed with a fluoroscope in a ster-
ile operating room with monitoring equipment for 
blood pressure, pulse rate, and pulse oximetry. The 
fluoroscope was adjusted over the lumbar area so that 
a transforaminal approach could be used for oblique 
views. After appropriate positioning of the fluoroscope, 
the needle was inserted  and local manesthetic was 
injected. An 18-gauge needle was introduced through 
the intervertebral foramen into the nucleus pulposus 
under fluoroscopic guidance. A lumbar discogram was 
performed using approximately 2 mL mixture of a dye 
(indigo carmine, Korea United Pharm, Seoul, Repub-
lic of Korea) and a non-iodinated contrast (iohexol, 
Omnipaque, GE Healthcare Korea, Seoul, Republic of 
Korea). Then, a K-wire was placed though the inserted 
needle. A dilator and outer cannula was introduced into 
the epidural space over the K-wire. After the removal 
of the dilator, a flexible epiduroscope (NeedleView CH, 
Lutronics, Ilsan, Republic of Korea) was introduced (Fig. 
1.). The epidural space and protruded disc was clearly 
visualized with saline irrigation. Using a straight laser 
fiber, laser ablation was performed using a 1414-nm 
scar formation, preservation of spinal stability, and 
an unencumbered ability to subsequently perform 
conventional open disc surgery.
Since its first introduction in by Choy 1986 (1), 
PLDD has been used widely. PLDD has been performed 
by laser ablation of the nucleus pulposus by means of a 
laser fiber under fluoroscopic guidance (1,3-5). The re-
sults of PLDD are good, but not without complications. 
Even with fluoroscopic guidance, dural puncture, nerve 
injuries, and thermal damage to the surrounding bone 
have been reported. The current scientific evidence is 
still limited, according to systematic reviews (6).
Transforaminal epiduroscopic laser ablation 
(TELA, Lutroics, Ilsan, Republic of Korea) was recently 
developed to inspect the epidural space and deliver 
therapeutic devices such as lasers or forceps, which can 
selectively eliminate or modulate pathologies. While 
PLDD removes the center of the nucleus pulposus un-
der fluoroscopic view, TELA ablates the herniated part 
of the nucleus pulposus under epiduroscopic vision. It 
is assumed that the selective removal of the herniated 
portion will induce more effective decompression with 
minimal complications. The purpose of this study was 
to evaluate the safety and effectiveness of TELA for 
selectively ablating the nucleus pulposus in single-level 
disc disease.
Table 1. Demographics of  the study patients.
Items
STEB 
group
(n = 56)
TELA 
group
(n = 56)
Age (years) 44.4 ± 15.0 43.2 ± 14.0
Sex M:F 34:22 34:22
Body mass index 24.3 ± 4.0 23.9 ± 4.2
Combined 
disease
Diabetes 2 1
Hypertension 6 5
Cardiovascular 
disease 4 3
Osteoporosis 5 4
Symptom duration (months) 3.2 ± 1.3 5 ± 1.0
Treated levels
L3-4 5 5
L4-5 38 40
L5-S1 13 11
Pain intensity 
(numeric rating 
scale)
Leg 6.3 ± 1.7 6.5 ± 2.6
Back 5.5 ± 2.2 6.6 ± 2.0
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Nd:YAG laser device (Accuplasti, Lutronics, Ilsan, Repub-
lic of Korea) and a tiny hole was made on the annulus. 
The safety and efficacy of the 1414-nm Nd:YAG laser de-
vice were described in another article (7). Then, using a 
side-firing laser, more volume was ablated with rotation 
of the fiber. When the protruded lesion was checked as 
satisfactorily decompressed by the epiduroscopic view, 
1 mL of 0.2% ropivacaine (AstraZeneca Korea, Seoul, 
Republic of Korea) and 1 mL of 0.5% dexamethasone 
(Yuhan, Seoul, Republic of Korea) was injected (Fig.2.).
STEB Procedure
STEB was performed in a sterile operation room 
equipped with a fluoroscope while the patient lay 
prone. After sterile preparation, draping, and local 
Fig. 1. a) The epiduroscope (NeedleView CH, BioVision, Ilsan, Republic of  Korea) with built-in fiber optics, 3.4-mm outer 
diameter, 1.85-mm working channel, 160-mm working length, and 17,000 pixels. This is disposable, and for single-use only. b) 
The video system with a non-disposable hand piece that contains a light source, camera, and video recording system (NeedleCam 
HD, BioVision, Ilsan, Republic of  Korea).
anesthesia with 1% lidocaine, a 12-cm-long, 22-gauge 
spinal needle was advanced into the region of the 
involved nerve root under fluoroscopic guidance. The 
target point was around the neural foramen. The 
needle position was checked by using the fluoroscope. 
Next, approximately 1 mL of contrast material (iohexol, 
Omnipaque, GE Healthcare Korea, Seoul, Republic of 
Korea) was injected to confirm epidural flow and to 
avoid intravascular, intradural, or soft-tissue infiltra-
tion. Posteroanterior and lateral spot radiographs were 
obtained to document distribution of the contrast 
material. After confirming epidural spread, 1 mL of 
0.2% ropivacaine (AstraZeneca Korea, Seoul, Republic 
of Korea) and 1 mL of 0.5% dexamethasone (Yuhan, 
Seoul, Republic of Korea) were slowly injected.
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Fig 2. Operative and epiduroscopic view. Through a) the working channel of  the epiduroscope and b) the surgical probe introduced 
to palpate the lesion. During the procedure, normal saline is continuously irrigated through c) the water inlet and d) outlet. The 
epiduroscopic view shows e) the laser probe on the surface of  the protruded disc. 
Outcome Measurement
The Visual Analogue Scale (VAS; score range: 0 to 
10, with 0 reflecting no pain) for back pain (VAS back) 
and leg pain (VAS leg), Odom’s criteria (which rates out-
comes as excellent, good, fair, or poor), the Oswestry 
disability index (ODI), and SF-12 scores were used to 
evaluate the clinical effectiveness of TELA and TFSEB. 
Effectiveness was measured in terms of pain reduction 
and functional improvement before treatment (as a 
control) and then at 1, 3, 6, and 12 months after treat-
ment. Successful pain relief was described as a 50% 
or more reduction in the patient’s VAS score; good or 
excellent results by Odom’s criteria were considered to 
reflect favorable outcomes.
Statistical Analysis
Cross-tabulation tables were analyzed using 
Fisher’s Exact and Pearson’s chi-square test. One-way 
ANOVA with repeated measures (RM-ANOVA) was 
used to identify a significant difference between the 
groups. Post hoc analysis among different groups was 
performed using the Bonferroni-corrected P-value. A P 
value < 0.05 was used a threshold for statistical signifi-
cance. All statistical analyses were performed with SPSS 
20.0 (IBM, Armonk, NY, USA).
Results
The baseline demographic characteristics are sum-
marized in Table 1. There were no statistical differences 
in the age, gender ratio, body mass index, combined 
diseases, treated levels, and preoperative pain intensity 
between the groups.
In total, 73.6%, 62.5%, 66.1%, and 50.0% of the 
STEB group had successful treatment responses at 1, 
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3, 6, and 12 months, respectively, compared to 71.4%, 
83.9%, 74.6%, and 76.4%, respectively, in the TELA 
group at the same time points. The TELA group had 
higher treatment success rates than the STEB group at 
3, 6, and 12 months postoperatively (P < 0.05, Table 2).
The results of the repeated variance analysis 
(RM-ANOVA) on changes in pain intensity, ODI 
scores, and SF-12 scores of the STEB group and the 
TELA group at the 5 measurement time points are 
shown in Figs. 3-6. The results of these intent-to-treat 
analyses showed that there were no significant dif-
ference in pain intensity, ODI scores, and SF-12 scores 
between the STEB group and the TELA group at each 
measurement point. Both groups showed significant 
improvements in leg pain and back pain immediately 
after the procedure. While leg pain increased after 6 
months in the STEB group, the TELA group continued 
to experience pain relief and the effect lasted up to 
1 year (Fig. 4). 
The TELA group had lower VAS scores for leg pain 
6 and 12 months postoperatively (P < 0.001, Fig. 4). Low 
back pain tended to decrease steadily in both groups, 
but the declining trend in the TELA group was steeper 
(Fig. 5) and they had lower back pain VAS scores 3, 6, 
and 12 months postoperative (P < 0.001, Fig. 5). The ODI 
values 6 and 12 months after surgery were lower in the 
TELA group (P < 0.001, Fig. 6), while the SF-12 values 6 
and 12 months after surgery were higher in the TELA 
group (P < 0.001, Fig. 7). 
Table 2. Proportion of  patients who showed more than a 
50% reduction in visual analog scale score compared to the 
preoperative state.
Follow-up (months)
STEB 
group
TELA 
group
P value
1 73.6% 71.4% 0.035
3 62.5% 83.9% 0.002
6 66.1% 74.6% 0.004
12 50.0% 76.4% 0.001
Fig 3. Illustrated view. The epiduroscope was introduced into the safe triangle. Using a straight laser fiber, laser ablation was 
performed using a 1414-nm Nd:YAG laser device and a tiny hole was made on the annulus. Then, using a side-firing laser, more 
volume was ablated with rotation of  the fiber.
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Fig 4. The intensity of  leg pain. (RM-ANOVA: Between 
groups, P = 0.002; within group P < 0.001; interaction P 
< 0.001).
Fig 5. The intensity of  back pain. (RM-ANOVA: Between 
group, P = 0.679; within group P < 0.001; interaction P < 
0.001).
Fig 6. ODI scores. (RM-ANOVA: Between groups, P = 
0.603; within group P < 0.001; interaction P = 0.127).
Fig 7. SF-12. (RM-ANOVA: Between groups, P = 0.040; 
within group P < 0.001; interaction P = 0.048).
Complications
No serious complications were noted in any of the 
participants. All complications were minor and self-
resolving. No additional surgery or intervention was 
required. Transient numbness was the most frequent 
compilation. Pain aggravation and allodynia were 
relieved spontaneously. There were no differences 
in complications between the STEB and TELA groups 
(Table 3).
discussion
Here, we investigated the role of transforaminal 
epiduroscopy with a 1414-nm Nd:YAG laser in mediat-
ing the positive effects of laser ablation on herniated 
lumbar discs. TELA was compared to STEB. ODI and SF-
12 improvement followed a similar time course to VAS 
improvement in both groups. However, clinically and 
functionally, greater long-term improvement was ob-
served in patients treated with TELA compared to STEB. 
The success rate was significantly higher in the TELA 
group 1 year postoperative. In our study, pain relief and 
functional improvement were found to be significantly 
greater statistically in the TELA group when compared 
to control group 1 year postoperative, indicating better 
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long-term sustainability. Clinically, numerous multi-
center studies with patients undergoing percutaneous 
disc decompression augmented with laser ablation 
reported increased success rates ranging from 70 to 
85% with laser ablation (2,8-13). In our study, 76.4% of 
the TELA group had a > 50% reduction in VAS 1 year 
post-surgery compared to 50.0% in the STEB group. 
There were no significant differences in complications 
between the STEB group and the TELA group.
Numerous studies have reported laser ablation 
with the use of laser as an alternative treatment to 
spinal surgeries, but the mechanisms of action of laser 
ablation has not been fully elucidated (2,8-13). Studies 
have shown that the biophysical mechanism of laser 
involves high-energy ablation which ablates the NP, de-
creases NP volume, and produces pain relief (7,14,15). 
A decrease in NP volume may enhance local circulation, 
whereas an increase in vascular supply stimulates mac-
rophages and migrating macrophages may desiccate 
the NP. The higher reduction of NP in TELA compared 
with STEB results in a net increase in pain relief. In 
addition, macrophages have been found to desiccate 
the NP to decrease its volume, a factor crucial for pain 
relief (16,17). It is possible that good visualization and 
sophisticated ablation enhances safe removal. On the 
other hand, saline irrigation, which is known to de-
crease inflammatory cytokines, may play a role in pain 
reduction.
We believe that TELA enhances the resorption of 
the herniated intervertebral disc by drilling a hole in 
the annulus fibrosus and partially removing the slipped 
nucleus pulposus with the use of a 1414-nm Nd:YAG la-
ser. This laser ablation may contribute to the increased 
success rates observed in the TELA group. In a previous 
study, the 1414-nm Nd:YAG laser has been found to 
significantly decrease intradiscal and intraspinal pres-
sure (7). Moon et al (7) reported a decrease in intradis-
cal and intraspinal pressure with laser ablation using a 
1414-nm Nd:YAG laser on porcine intervertebral discs. 
In the same model, but in combination with a 1064-nm 
Nd:YAG laser, Choy et al (15) showed that intradiscal 
pressure was significantly decreased without any ad-
verse effects on the surrounding tissues. Others studies 
(1,18) have also demonstrated similar decreases intra-
discal pressure in cadavers and animals after treatment 
with various lasers. In addition, Lee et al (19) reported 
that the epidural application of a 1414-nm Nd:YAG 
laser was effective for ablating the nociceptors on the 
surface of the annulus.
There are limitations to this study. First, while this 
preliminary investigation into laser ablation suggests 
an association with nucleus pulposus desiccation, the 
results also suggest that further investigation is war-
ranted into this phenomenon. Second, we did not 
perform MRI scans in every patient. It remains unclear 
whether a better outcome could be achieved by direct 
ablation of the annulus. Third, in this study setting, 
whether the true effect of TELA is due to immediate de-
compression or accelerated desiccation is also unclear. 
Despite these limitations, although the effectiveness of 
intradiscal laser ablation has been widely reported, this 
study is the first to report targeted disc ablation with a 
1414-nm Nd:YAG laser.
conclusion
The TELA procedure appears to be  superior to the 
STEB procedure because is shows results of less pain and 
better quality of life over a longer time period. Accord-
ing to our results, TELA may be a reasonable alternative 
to conventional interventions or open surgery in single-
level disc disease.
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Table 3. Complications
 STEB group TELA group
Increased pain 2 3
Intrathecal injection 0 0
Allodynia 1 1
Numbness 3 4
Infection 0 0
Hematoma 0 0
Nerve injury 0 0
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